The Cryosleep Market grows at Highest Pace Owing to Rising Geriatric Population

 Cryosleep, also known as cryogenic freezing or cryopreservation, refers to the process of preserving a human body by cooling it down to very low subzero temperatures, generally with liquid nitrogen (at -196°C or -320°F) or liquid helium. Cryosleep has been proposed as a means of preserving an injured person until they can be healed, or as a way to wait until anti-aging treatments are developed. Cryosleep techniques involve reducing the metabolism to almost zero by cooling the body. Organs, tissues, cell structures are preserved with minimum damage using cryoprotectants which replace water and prevent ice formation. The global cryosleep market is gradually gaining traction due to increased life expectancy and growing geriatric population who are more prone to chronic diseases.


The Global Cryosleep Market is estimated to be valued at US$ 3.67 Mn in 2024 and is expected to exhibit a CAGR of 8.9% over the forecast period 2024 to 2030.


Key Takeaways

Key players operating in the cryosleep market are Ipsen Pharma, Allergan, Acorda Therapeutics, Inc., Merz Pharma, Teva Pharmaceutical Industries Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Ltd., Johnson & Johnson Private Limited, Zydus Cadila, F. Hoffmann-La Roche Ltd., and Elite Pharmaceuticals Inc. These players are investing heavily in R&D to develop advanced cryosleep techniques.

The rising geriatric population globally is a major factor driving the growth of The Cryosleep Market. As per the UN data, the number of people aged 65 and above is projected to grow to 1.5 billion in 2050 from 703 million in 2019. Growing old age leads to increased risks of life-threatening health conditions requiring cryosleep.

Technological advancements are also boosting the cryosleep market. Researchers are developing equipment that can preserve tissues and cells without causing any ice formation using vitrification process. Novel cryoprotective substances are replacing traditional cryoprotectants to increase post-thaw cell viability after cryopreservation.

Market Trends
The use of stem cells in cryosleep procedures is gaining popularity. Stem cells repair and regenerate damaged tissues and are being explored to revive cryopreserved organs and reduce reperfusion injury after thawing. Another trend is the growing adoption of personalized cryosleep approaches tailored as per individual's physiology and medical condition. Companies are also focusing on developing compact table-top cryopreservation systems for point-of-care storage applications.

Market Opportunities
Increasing investment in R&D of organ cryopreservation technologies for applications in transplant medicine present significant opportunities. There is scope to develop improved vitrification protocols for cryopreserving cells, tissues and even whole organs. Growing gerontology research related to treating aging-associated diseases through cryosleep offers opportunities for market expansion.

Impact of COVID-19 on Cryosleep Market Growth

The outbreak of the COVID-19 pandemic has significantly impacted the growth of the cryosleep market. During the initial phases of the pandemic, most of the cryosleep procedures were put on hold as healthcare resources were diverted to handle the rising number of coronavirus cases. This led to a decline in the demand for cryosleep services. However, with the gradual lifting of lockdowns and resumption of non-emergency treatments, the cryosleep market is recovering steadily.

Several measures are being undertaken by cryosleep service providers to minimize the risks of virus transmission. Strict screening protocols and COVID-19 testing of patients before procedures are being implemented. Higher standards of sanitization and disinfection of facilities are ensuring safest possible environment for cryopreservation. Technological advancements like remote monitoring systems allow caregivers to supervise patients remotely, reducing physical interactions.

Still, concerns around the spread of infection and potential complications in immunosuppressed cryosleep patients continue to impact the market. Further research on the virus and successful rollout of vaccines are expected to boost confidence and fuel the market growth over the coming years. Service providers will need to focus on educating people about enhanced safety measures to revive demand for their services in the post-pandemic period.

Geographical Regions with High Concentration in Cryosleep Market

North America currently dominates the cryosleep market globally, accounting for the largest share in terms of revenue. This can be attributed to the availability of favorable reimbursement policies, rising cancer prevalence driving interest in oncology cryopreservation, and increasing research in regenerative medicine applications of cryosleep in the region.

Europe is another major regional market for cryosleep given the growing demand for fertility preservation and presence of major industry players. However, Asia Pacific is projected to witness fastest market growth during the forecast period. This is due to rising medical tourism, growing health expenditures, increasing public awareness about advanced cryopreservation techniques, and expansion activities of leading companies in developing nations.

Fastest Growing Geographical Region in Cryosleep Market

The Asia Pacific region holds immense potential and is expected to be the fastest growing market for cryosleep globally between 2024-2030. Factors such as the rise of China, India and other Southeast Asian countries as prominent medical tourism destinations, significant population base ensuring larger patient pools, and favorable government initiatives to boost the healthcare sector are driving the APAC cryosleep market.

Steadily increasing investments by key industry players in setting up advanced treatment and research facilities across Asia are also propelling the regional market growth. Furthermore, growing disposable incomes, awareness about advanced treatments, and availability of lower costs relative to developed nations are encouraging more patients in APAC to opt for cryopreservation procedures. Overall, with improving accessibility and declining taboos around unconventional treatments, the Asia Pacific cryosleep market will continue its rapid expansion over the coming years.

 

Get more insights on Cryosleep Market

Comments

Post a Comment

Popular posts from this blog

Vegan Yogurt Market is Poised for Growth Driven by Rising Health Consciousness

Image
Vegan yogurt is a dairy-free alternative to conventional yogurt made from plant-based milk such as soy, almond, oat, coconut or rice. It provides similar texture and taste to dairy yogurt but without any animal products.Vegan yogurt offers several health advantages over dairy yogurt as it is devoid of lactose, cholesterol and saturated fats. The growing number of people adopting vegan and flexitarian diets has driven the demand for plant-based dairy alternatives like vegan yogurt. The global vegan yogurt market is estimated to be valued at US$ 4.15 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031. Key Takeaways Key players- Met Fods, Cocos Organic, Hain Celestial, EasiYo Product Limited, Danone, General Mills Inc., Stonyfield Far, Inc., Daiya Foods Inc.m Good Karma foods, Inc.m Hudson River Foodsm NANCY'S, Kite Hill, COYO Pty lTd., Nush Foods, Chobani, LLC, Barambah Oraganics Pty Ltd., Blue Diamond Growers, Dean Foodsm General Mills Inc...
Read more

Hypoglycemic Drugs Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes in the Geriatric Population

Image
Hypoglycemic drugs or anti-diabetic drugs are medications used to treat diabetes mellitus by lowering blood glucose levels. Some key hypoglycemic drugs include insulin, sulfonylureas, metformin, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and GLP-1 receptor agonists. These drugs help control blood sugar levels in diabetics and prevent or delay diabetes-related health complications. The global hypoglycemic drugs market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The growth of the global hypoglycemic drugs market is majorly driven by the increasing prevalence of diabetes in the geriatric population globally. As per estimates, around 1 in every 11 people aged 65 years and above have diabetes. Further, the number of people with diabetes in this age group is anticipated to grow from 25.9 million in 2017 to...
Read more

Clinical Trials Rising with Digital Technologies Adoption

Image
 Clinical trials support services play a vital role in assisting sponsors and life science companies to conduct clinical trials in a precise and well-organized manner.These services assist pharmaceutical companies in patient recruitment, data management, site management, and overall clinical trial management. With rising complexities in clinical trials owing to integration of technologies like telehealth and remote patient monitoring, the demand for these support services is growing substantially. The global Clinical Trials Support Services Market is estimated to be valued at US$ 22.38 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing adoption of digital technologies across clinical trials is a key trend accelerating the growth of the clinical trials support services market. Digital tools like electronic data capture, clinical trial manag...
Read more